$OCAT Company News Osiris stem-cell therapy wi
Post# of 94145
Posted On: 01/04/2015 12:31:17 PM
$OCAT Company News
Osiris stem-cell therapy wins Canadian approval 4:43 p.m. May 17, 2012 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Regeneron, Cephalon boost biotech stocks 2:29 p.m. May 2, 2011 - Val Brickates Kennedy
Stem cell researchers gain on U.S. court decision 9:14 a.m. May 2, 2011 - Val Brickates Kennedy
Fighting diabetes, other diseases, with live cells 6:08 p.m. March 10, 2011 - Kristen Gerencher
Drug stocks rally with broader market 1:04 p.m. March 10, 2009 - Val Brickates Kennedy
Merck, Schering-Plough merger fails to stoke sector 2:59 p.m. March 9, 2009 - Val Brickates Kennedy
Drug stocks dip; Seattle Genetics soars on deal 4:55 p.m. Jan. 8, 2007 - Val Brickates Kennedy
Drug stocks mixed; stem cell companies gain on funding hopes 1:26 p.m. Jan. 5, 2007 - Val Brickates Kennedy
Biggest stock gainers and decliners - Jan. 4 5:46 p.m. Jan. 4, 2007 - Michael Baron
Stem-cell rally as sector moves broadly higher 4:44 p.m. Jan. 4, 2007 - Val Brickates Kennedy
Fund manager finding few bargains among small-cap stocks 8:09 p.m. Dec. 6, 2006 - MarketWatch
Overvalued Small-Caps? 12:45 p.m. Dec. 6, 2006 - Bill Disbrow
Pharma stocks fall; Merck slumps as tax-liability questions arise 5:46 p.m. Nov. 8, 2006 - Val Brickates Kennedy
Friday's biggest stock gainers and decliners 3:27 p.m. Aug. 25, 2006 - Michael Baron
Advanced Cell to receive $13.5 mln from financing deals 9:47 a.m. Aug. 25, 2006 - Gabriel Madway
Advanced Cell Technology shares down 13% at $1.40 9:18 a.m. Aug. 25, 2006 - Gabriel Madway
Advanced Cell: Repriced warrants to generate add'l $5M 9:16 a.m. Aug. 25, 2006 - Gabriel Madway
Advanced Cell: Add'l investment to provide $8.5M in capital 9:14 a.m. Aug. 25, 2006 - Gabriel Madway
The Butterfly Effect: Advanced Cell Technology Becomes Ocata Therapeutics (OCAT) 9:58 a.m. Dec. 8, 2014 - Seeking Alpha
A Timely Interview With BioTime's CEO And His Chief Commercial Officer 11:39 a.m. Nov. 17, 2014 - Seeking Alpha
Advanced Cell Technology: All Systems Go 11:14 a.m. Nov. 11, 2014 - Seeking Alpha
10-Q: ADVANCED CELL TECHNOLOGY, INC. 4:23 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
StemCells Inc. Faces Tough Times Ahead 10:36 a.m. Nov. 10, 2014 - Seeking Alpha
Advanced Cell Technology Is Severely Undervalued 5:32 p.m. Nov. 7, 2014 - Seeking Alpha
Time To Sell Advanced Cell Technology And Buy StemCells, Inc. 10:09 a.m. Nov. 3, 2014 - Seeking Alpha
Advanced Cell Technology Is Scaling Up Its Blood Program 7:35 a.m. Oct. 27, 2014 - Seeking Alpha
Advanced Cell Technology Has Groundbreaking Results 3:06 p.m. Oct. 15, 2014 - Seeking Alpha
Update: Advanced Cell Technology Interim Results And Shelf Offerings 8:37 a.m. Oct. 15, 2014 - Seeking Alpha
RPE cells safety data published online in The Lancet 6:50 a.m. Oct. 15, 2014 - Seeking Alpha
Stem Cells Show Potential Benefits for Eye Diseases 5:53 p.m. Oct. 14, 2014 - The Wall Street Journal Interactive Edition
Advanced Cell Technology's Turnaround Has Near-Term Catalysts 4:07 p.m. Oct. 6, 2014 - Seeking Alpha
BioTime Is Right On Time: Files IND For AMD 3:32 p.m. Oct. 6, 2014 - Seeking Alpha
Advanced Cell Technology And Dilution: Do We Really Have A Rational Choice? 2:03 p.m. Sept. 29, 2014 - Seeking Alpha
Final patient treated in UK SMD trial 9:01 a.m. Sept. 25, 2014 - Seeking Alpha
A Repudiation Of Advance Cell Technology's 'Whisper' Results 9:36 a.m. Sept. 20, 2014 - Seeking Alpha
SEC Targets Timing of Insiders' Trade Notices 6:31 p.m. Sept. 10, 2014 - The Wall Street Journal Interactive Edition
ACTC completes 1:100 reverse split 4:56 p.m. Aug. 27, 2014 - Seeking Alpha
Advanced Cell Technology: Maximizing Profit On Reverse Splits And Phase I Results 10:24 a.m. Aug. 26, 2014 - Seeking Alpha
Ocata Therapeutics Announces Proposed Underwritten Offering of Common Stock 4:11 p.m. Dec. 2, 2014 - BusinessWire - BZX
Ocata Therapeutics to Present at 26th Annual Piper Jaffray Health Care Conference 9:19 a.m. Nov. 25, 2014 - BusinessWire - BZX
Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation from the European Medicines Agency 9:22 a.m. Nov. 24, 2014 - BusinessWire - BZX
Bankruptcies, Breakouts, and Busts; What's Happening in Biotech? 11:34 a.m. Nov. 11, 2014 - ACCESSWIRE
Advanced Cell Technology to Host Conference Call and Webcast to Provide a Corporate Update for the Third Quarter of 2014 9:09 a.m. Nov. 7, 2014 - BusinessWire - BZX
Advanced Cell Technology Appoints LeRoux Jooste as SVP of Business Development & Chief Commercial Officer 8:03 a.m. Oct. 20, 2014 - BusinessWire - BZX
ACT Reports the Publication of Research on the Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem Cells (iPSC) 8:09 a.m. Oct. 17, 2014 - BusinessWire - BZX
ACT Announces Positive Results from Two Clinical Trials Published in The Lancet Using Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells for the Treatment of Macular Degeneration 5:33 p.m. Oct. 14, 2014 - BusinessWire - BZX
Advanced Cell Technology Announces Final Patient Treated in Stargardt’s Macular Degeneration Phase 1 Trial in the United Kingdom 8:17 a.m. Sept. 25, 2014 - BusinessWire - BZX
Advanced Cell Technology Announces Issuance of Patent Covering Dendritic Cells Manufacturing from Renewable Stem Cell Sources 8:17 a.m. Sept. 5, 2014 - BusinessWire - BZX
Distinguished Scientists Join Advanced Cell Technology’s New Scientific Advisory Board 8:12 a.m. Sept. 2, 2014 - BusinessWire - BZX
Advanced Cell Technology Announces 1:100 Reverse Stock Split 4:13 p.m. Aug. 27, 2014 - BusinessWire - BZX
Advanced Cell Technology to Host Conference Call to Provide a Corporate Update 11:12 p.m. Aug. 6, 2014 - BusinessWire - BZX
Advanced Cell Technology Secures $30 Million Equity Facility from Lincoln Park Capital 8:05 a.m. July 3, 2014 - BusinessWire - BZX
Advanced Cell Technology, Inc. Announces Paul K. Wotton Ph.D. Recognized as Ernst & Young (EY) 2014 Entrepreneur of the Year™ for New Jersey Region 8:02 a.m. July 1, 2014 - BusinessWire - BZX
OTC Stocks Daily Trading Focus: Windstream Technologies, Inc. Blue Earth, Inc. Creative Edge Nutrition, Inc. Brainstorm Cell Therapeutics, Inc., Advanced Cell Technology, Inc. 7:00 a.m. July 1, 2014 - PR Newswire - PRF
Advanced Cell Technology Appoints Paul K. Wotton, Ph.D, President and Chief Executive Officer 8:10 a.m. June 24, 2014 - BusinessWire - BZX
Advanced Cell Technology to Host Conference Call to Provide a Corporate Update; Announces Settlement of Litigation 7:45 a.m. June 6, 2014 - BusinessWire - BZX
Surveyed U.S. Retinal Specialists Are Highly Receptive to Pipeline Agents Targeting Geographic Atrophy, the Dry Form of Advanced Age-Related Macular Degeneration 9:00 a.m. June 4, 2014 - PR Newswire - PRF
Advanced Cell Technology’s Chief Scientific Officer Dr. Robert Lanza Named One of TIME Magazine’s 100 Most Influential People in the World 9:42 a.m. April 24, 2014 - BusinessWire - BZX
Osiris stem-cell therapy wins Canadian approval 4:43 p.m. May 17, 2012 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Regeneron, Cephalon boost biotech stocks 2:29 p.m. May 2, 2011 - Val Brickates Kennedy
Stem cell researchers gain on U.S. court decision 9:14 a.m. May 2, 2011 - Val Brickates Kennedy
Fighting diabetes, other diseases, with live cells 6:08 p.m. March 10, 2011 - Kristen Gerencher
Drug stocks rally with broader market 1:04 p.m. March 10, 2009 - Val Brickates Kennedy
Merck, Schering-Plough merger fails to stoke sector 2:59 p.m. March 9, 2009 - Val Brickates Kennedy
Drug stocks dip; Seattle Genetics soars on deal 4:55 p.m. Jan. 8, 2007 - Val Brickates Kennedy
Drug stocks mixed; stem cell companies gain on funding hopes 1:26 p.m. Jan. 5, 2007 - Val Brickates Kennedy
Biggest stock gainers and decliners - Jan. 4 5:46 p.m. Jan. 4, 2007 - Michael Baron
Stem-cell rally as sector moves broadly higher 4:44 p.m. Jan. 4, 2007 - Val Brickates Kennedy
Fund manager finding few bargains among small-cap stocks 8:09 p.m. Dec. 6, 2006 - MarketWatch
Overvalued Small-Caps? 12:45 p.m. Dec. 6, 2006 - Bill Disbrow
Pharma stocks fall; Merck slumps as tax-liability questions arise 5:46 p.m. Nov. 8, 2006 - Val Brickates Kennedy
Friday's biggest stock gainers and decliners 3:27 p.m. Aug. 25, 2006 - Michael Baron
Advanced Cell to receive $13.5 mln from financing deals 9:47 a.m. Aug. 25, 2006 - Gabriel Madway
Advanced Cell Technology shares down 13% at $1.40 9:18 a.m. Aug. 25, 2006 - Gabriel Madway
Advanced Cell: Repriced warrants to generate add'l $5M 9:16 a.m. Aug. 25, 2006 - Gabriel Madway
Advanced Cell: Add'l investment to provide $8.5M in capital 9:14 a.m. Aug. 25, 2006 - Gabriel Madway
The Butterfly Effect: Advanced Cell Technology Becomes Ocata Therapeutics (OCAT) 9:58 a.m. Dec. 8, 2014 - Seeking Alpha
A Timely Interview With BioTime's CEO And His Chief Commercial Officer 11:39 a.m. Nov. 17, 2014 - Seeking Alpha
Advanced Cell Technology: All Systems Go 11:14 a.m. Nov. 11, 2014 - Seeking Alpha
10-Q: ADVANCED CELL TECHNOLOGY, INC. 4:23 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
StemCells Inc. Faces Tough Times Ahead 10:36 a.m. Nov. 10, 2014 - Seeking Alpha
Advanced Cell Technology Is Severely Undervalued 5:32 p.m. Nov. 7, 2014 - Seeking Alpha
Time To Sell Advanced Cell Technology And Buy StemCells, Inc. 10:09 a.m. Nov. 3, 2014 - Seeking Alpha
Advanced Cell Technology Is Scaling Up Its Blood Program 7:35 a.m. Oct. 27, 2014 - Seeking Alpha
Advanced Cell Technology Has Groundbreaking Results 3:06 p.m. Oct. 15, 2014 - Seeking Alpha
Update: Advanced Cell Technology Interim Results And Shelf Offerings 8:37 a.m. Oct. 15, 2014 - Seeking Alpha
RPE cells safety data published online in The Lancet 6:50 a.m. Oct. 15, 2014 - Seeking Alpha
Stem Cells Show Potential Benefits for Eye Diseases 5:53 p.m. Oct. 14, 2014 - The Wall Street Journal Interactive Edition
Advanced Cell Technology's Turnaround Has Near-Term Catalysts 4:07 p.m. Oct. 6, 2014 - Seeking Alpha
BioTime Is Right On Time: Files IND For AMD 3:32 p.m. Oct. 6, 2014 - Seeking Alpha
Advanced Cell Technology And Dilution: Do We Really Have A Rational Choice? 2:03 p.m. Sept. 29, 2014 - Seeking Alpha
Final patient treated in UK SMD trial 9:01 a.m. Sept. 25, 2014 - Seeking Alpha
A Repudiation Of Advance Cell Technology's 'Whisper' Results 9:36 a.m. Sept. 20, 2014 - Seeking Alpha
SEC Targets Timing of Insiders' Trade Notices 6:31 p.m. Sept. 10, 2014 - The Wall Street Journal Interactive Edition
ACTC completes 1:100 reverse split 4:56 p.m. Aug. 27, 2014 - Seeking Alpha
Advanced Cell Technology: Maximizing Profit On Reverse Splits And Phase I Results 10:24 a.m. Aug. 26, 2014 - Seeking Alpha
Ocata Therapeutics Announces Proposed Underwritten Offering of Common Stock 4:11 p.m. Dec. 2, 2014 - BusinessWire - BZX
Ocata Therapeutics to Present at 26th Annual Piper Jaffray Health Care Conference 9:19 a.m. Nov. 25, 2014 - BusinessWire - BZX
Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation from the European Medicines Agency 9:22 a.m. Nov. 24, 2014 - BusinessWire - BZX
Bankruptcies, Breakouts, and Busts; What's Happening in Biotech? 11:34 a.m. Nov. 11, 2014 - ACCESSWIRE
Advanced Cell Technology to Host Conference Call and Webcast to Provide a Corporate Update for the Third Quarter of 2014 9:09 a.m. Nov. 7, 2014 - BusinessWire - BZX
Advanced Cell Technology Appoints LeRoux Jooste as SVP of Business Development & Chief Commercial Officer 8:03 a.m. Oct. 20, 2014 - BusinessWire - BZX
ACT Reports the Publication of Research on the Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem Cells (iPSC) 8:09 a.m. Oct. 17, 2014 - BusinessWire - BZX
ACT Announces Positive Results from Two Clinical Trials Published in The Lancet Using Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells for the Treatment of Macular Degeneration 5:33 p.m. Oct. 14, 2014 - BusinessWire - BZX
Advanced Cell Technology Announces Final Patient Treated in Stargardt’s Macular Degeneration Phase 1 Trial in the United Kingdom 8:17 a.m. Sept. 25, 2014 - BusinessWire - BZX
Advanced Cell Technology Announces Issuance of Patent Covering Dendritic Cells Manufacturing from Renewable Stem Cell Sources 8:17 a.m. Sept. 5, 2014 - BusinessWire - BZX
Distinguished Scientists Join Advanced Cell Technology’s New Scientific Advisory Board 8:12 a.m. Sept. 2, 2014 - BusinessWire - BZX
Advanced Cell Technology Announces 1:100 Reverse Stock Split 4:13 p.m. Aug. 27, 2014 - BusinessWire - BZX
Advanced Cell Technology to Host Conference Call to Provide a Corporate Update 11:12 p.m. Aug. 6, 2014 - BusinessWire - BZX
Advanced Cell Technology Secures $30 Million Equity Facility from Lincoln Park Capital 8:05 a.m. July 3, 2014 - BusinessWire - BZX
Advanced Cell Technology, Inc. Announces Paul K. Wotton Ph.D. Recognized as Ernst & Young (EY) 2014 Entrepreneur of the Year™ for New Jersey Region 8:02 a.m. July 1, 2014 - BusinessWire - BZX
OTC Stocks Daily Trading Focus: Windstream Technologies, Inc. Blue Earth, Inc. Creative Edge Nutrition, Inc. Brainstorm Cell Therapeutics, Inc., Advanced Cell Technology, Inc. 7:00 a.m. July 1, 2014 - PR Newswire - PRF
Advanced Cell Technology Appoints Paul K. Wotton, Ph.D, President and Chief Executive Officer 8:10 a.m. June 24, 2014 - BusinessWire - BZX
Advanced Cell Technology to Host Conference Call to Provide a Corporate Update; Announces Settlement of Litigation 7:45 a.m. June 6, 2014 - BusinessWire - BZX
Surveyed U.S. Retinal Specialists Are Highly Receptive to Pipeline Agents Targeting Geographic Atrophy, the Dry Form of Advanced Age-Related Macular Degeneration 9:00 a.m. June 4, 2014 - PR Newswire - PRF
Advanced Cell Technology’s Chief Scientific Officer Dr. Robert Lanza Named One of TIME Magazine’s 100 Most Influential People in the World 9:42 a.m. April 24, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼